Rigel Pharmaceuticals Inc (RIGL)
P/OCF Ratio
11.42×
TTM · Retrieved:
RIGL P/OCF Ratio
Current (TTM)11.42×retrieved
Current (TTM)11.42×retrieved
RIGL Quarterly P/OCF Ratio (0.00× → 23.66×)
Latest values, visible window
High-resolution chart · PNG
RIGL p/ocf ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | P/OCF Ratio |
|---|---|
| 23.6624× | |
| 182.7011× | |
| 35.0493× | |
| 21.2649× | |
| 10.9698× | |
| -358.7524× | |
| 20.4663× | |
| 13.1357× | |
| 488.699× | |
| -46.8318× | |
| -40.5419× | |
| -138.5642× | |
| 37.7559× | |
| -56.2371× | |
| -11.8342× | |
| -15.3332× | |
| -15.0667× | |
| -20.0337× | |
| -23.7524× | |
| -60.2424× | |
| 13.3772× | |
| -29.1013× | |
| -37.9936× | |
| -20.8106× | |
| -21.9749× | |
| -84.9703× | |
| -37.1755× | |
| -21.4077× | |
| -25.4033× | |
| -710.9866× | |
| 33.1094× | |
| -26.0275× | |
| -16.9397× | |
| -22.2608× | |
| -28.389× | |
| -17.9762× | |
| -17.1764× | |
| -18.1108× | |
| -18.9002× | |
| -15.52× | |
| -11.1899× | |
| -8.4016× | |
| -19.5543× | |
| -23.1172× | |
| -15.5918× | |
| 17.4739× | |
| -13.2414× | |
| -9.291× | |
| -15.9313× | |
| -20.673× | |
| -13.1876× | |
| -15.0894× | |
| -25.358× | |
| -43.5741× | |
| -48.5253× | |
| -84.2471× | |
| -72.1535× | |
| -55.6579× | |
| -99.1389× | |
| -134.848× | |
| -125.2174× | |
| -80.2636× | |
| 382.4694× | |
| -230.6335× | |
| 47.6249× | |
| -179.3492× | |
| -212.2691× | |
| -123.1809× | |
| -177.5362× | |
| -77.5349× | |
| -107.8526× | |
| -348.2413× | |
| -333.9537× | |
| -237.157× | |
| -1,043.4002× | |
| -222.1326× | |
| -169.0176× | |
| -177.1706× | |
| -273.6413× | |
| -314.173× | |
| -364.2445× | |
| -281.0605× | |
| -456.6662× | |
| -401.1155× | |
| -366.3976× | |
| -518.8653× | |
| -905.1507× | |
| -394.342× | |
| -232.6063× | |
| -335.6523× | |
| -312.8261× | |
| -21.3418× | |
| -68.7079× | |
| -79.5448× | |
| -34.4832× | |
| -169.4689× | |
| -119.6211× | |
| -327.9584× | |
| -676.6875× | |
| -685.5834× |